Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Christopher Ngai's publication output changed over time?
ScholarIQpublication output · 1995–2024
Output grew0% over the shown period — from 1 works in 1995 to 1 in 2024.
1
3
1
1
2
1
1
1995201520162017202120232024
What are the most-cited papers on Christopher Ngai?
ScholarIQmost cited works
Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease
Richard Mayeux, Ruth Ottman, Gladys E. Maestre, Christopher Ngai, M.‐X. Tang, H N Ginsberg, Michael Chun, Benjamin Tycko, Michael L. Shelanski
Neurology. 1995585 CitationsOPEN ACCESS
A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy
C.S. Kwon, Patrick Daniele, Anna Forsythe, Christopher Ngai
Journal of health economics and outcomes research. 202162 CitationsOPEN ACCESS
A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy
C.S. Kwon, Patrick Daniele, Anna Forsythe, Christopher Ngai
Journal of health economics and outcomes research. 202147 CitationsOPEN ACCESS
The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States
Dominick Latrémouille-Viau, Jane Chang, Annie Guérin, Sherry Shi, Ed Wang, Justin Yu, Christopher Ngai
Journal of Medical Economics. 201621 CitationsOPEN ACCESS
Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States
Lauren Ramjee, Nesrin Vurgun, Christopher Ngai, Mit Patel, Gabriel Tremblay
ClinicoEconomics and Outcomes Research. 202310 CitationsOPEN ACCESS
Related on ScholarIQ
Immunitas Therapeutics (United States)
Institution
Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease
Paper
A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy
Paper
A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy
Paper
The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States
Paper
Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States
Paper